Unbound MEDLINE

Pre- Versus Postmenopausal Age, Estradiol, and Peptide-Secretagogue Type Determine Pulsatile Growth Hormone Secretion in Healthy Women: Studies Using Submaximal Agonist Drive and an Estrogen Clamp. The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] Journal article

 
TitlePre- Versus Postmenopausal Age, Estradiol, and Peptide-Secretagogue Type Determine Pulsatile Growth Hormone Secretion in Healthy Women: Studies Using Submaximal Agonist Drive and an Estrogen Clamp.
Author(s)Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY, Veldhuis JD 
InstitutionDepartment of Obstetrics and Gynecology (S.B.H.), Biomedical Statistics and Informatics (D.R.S.), Endocrine Research Unit (J.N.B., K.L.M., D.E., J.M.M., J.D.V.), Mayo School of Graduate Medical Education, Clinical Translational Research Center, Mayo Clinic, Rochester, Minnesota 55905; and Endocrine Division (C.Y.B.), Department of Medicine, Tulane University Health Science Center, New Orleans, Louisiana 70112.
SourceJ Clin Endocrinol Metab 2009 Oct 26.
AbstractContext: GH-releasing peptide (GHRP), GHRH, and somatostatin are physiological regulators of pulsatile GH secretion. Hypothesis: Age, independently of abdominal visceral fat (AVF) and basal (nonpulsatile) GH secretion, damps pulsatile GH secretion driven by physiological (rather than pharmacological) amounts of GHRP and GHRH in an experimentally controlled estradiol (E2) milieu. Design and
Setting: A prospectively randomized, double-blind parallel-cohort study was conducted at an academic medical center.
Participants: Community-dwelling healthy premenopausal (PRE, age 24 +/- 0.8 yr, n = 20) and postmenopausal (POST, age 63 +/- 1.8 yr, n = 22) women participated in the study.
Interventions: Gonadal-axis down-regulation with leuprolide was followed by randomized addback of placebo or transdermal E2 and separate-day iv bolus injections of a half-maximally stimulatory dose of GHRP-2 or GHRH (each 0.33 mug/kg). Analysis: Three-way analysis of covariance included main factors age, E2 status, and secretagogue type and covariates AVF and basal GH secretion.
Results: Submaximally stimulated pulsatile GH secretion was positively determined by PRE vs. POST age (P < 0.001), E2 repletion vs. depletion (P = 0.001) and GHRP-2 vs. GHRH stimulation (P < 0.001), after adjustment for AVF and basal secretion. E2 vs. placebo elevated fasting mean GH concentrations in both PRE and POST women (P = 0.006) but increased basal (nonpulsatile) GH secretion in PRE only (P = 0.002). PRE vs. POST age prolonged GHRH-driven GH secretory bursts by 36% (P = 0.006).
Conclusion: PRE vs. POST age, E2 availability, and physiological peptide drive are triple determinants of pulsatile GH secretion independently of abdominal visceral fat and nonpulsatile GH secretion in healthy women.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19858315
  
Advertise on this site.